CT imaging correlates of genomic expression for oral cavity squamous cell carcinoma

American Journal of Neuroradiology

Volumn 34, Issue 9, 2013, Pages 1818-1822

  Pickering, C R ^a   Shah, K ^a   Ahmed, S ^a   Rao, A ^a   Frederick, M J ^a   Zhang, J ^a   Unruh, A K ^a   Wang, J ^a   Ginsberg, L E ^a   Kumar, A J ^a   Myers, J N ^a   Hamilton, J D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANGIOGENESIS; CANCER GROWTH; CANCER SIZE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PERINEURAL INVASION; PREOPERATIVE PERIOD; PRIMARY TUMOR; TUMOR INVASION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENIC PROTEINS; CARCINOMA, SQUAMOUS CELL; FEMALE; GENES, BCL-1; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; STATISTICS AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85047687252     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3635     Document Type: Conference Paper

References (27)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917
2. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300
3. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011;11:9-22
4. Argiris A, Karamouzis MV, Raben D, et al. Head and neck cancer. Lancet 2008;371:1695-709
5. Agrawal N, Frederick MJ, Pickering CR, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011;333:1154-57
6. Spector ME, Gallagher KK, Light E, et al. Matted nodes: poor prognostic markerinoropharyngealsquamous cell carcinoma independent of HPV and EGFR status. Head Neck 2012;34:1727-33
7. Makkat S, Luypaert R, Stadnik T, et al. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor2status and clinicopathologic findings-preliminary results. Radiology 2008;249:471-82
8. Diehn M, Nardini C, Wang DS, et al. Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A 2008;105:5213-18
9. Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007;21:2683-710
10. Leo C, Giaccia AJ, Denko NC. The hypoxic tumor microenvironment and gene expression. Semin Radiat Oncol 2004;14:207-14
11. Maia AC, Jr., Malheiros SM, da Rocha AJ, et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 2005;26:777-83
12. Shimizu H, Kumabe T, Shirane R, et al. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 2000;21:659-65
13. Emblem KE, Scheie D, Due-Tonnessen P, et al. Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes. AJNR Am J Neuroradiol 2008;29:1664-70
14. Jenkinson MD, du Plessis DG, Smith TS, et al. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain 2006;129:1884-91
15. Kanematsu M, Osada S, Amaoka N, et al. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with angiographically assisted CT. AJR Am J Roentgenol 2004;183:1585-93
16. Emblem KE, Bjornerud A, Mouridsen K, et al. T (1) - and T (2) - dominant extravasation correctioninDSC-MRI: part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients. J Cereb Blood Flow Metab 2011;31:2054-64
17. Zinn PO, Mahajan B, Sathyan P, et al. Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One 2011;6:e25451
18. Rubin Grandis J, Melhem MF, Gooding WE, et al. Levels of TGF-alpha and EGFR proteininhead and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998;90:824-32
19. Pectasides E, Rampias T, Kountourakis P, et al. Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma. Clin Cancer Res 2011;17:2947-54
20. Bauman JE, Michel LS, Chung CH. New promising molecular targets in head and neck squamous cell carcinoma. Curr Opin Oncol 2012;24:235-42
21. Choi BB, Kim SH, Kang BJ, et al. Diffusion-weighted imaging and FDG PET/CT: predictingthe prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma. World J Surg Oncol 2012;10:126
22. Mahdey HM, Ramanathan A, Ismail SM, et al. Cyclin D1 amplificationintongue and cheek squamous cell carcinoma. Asian Pac J Cancer Prev 2011;12:2199-204
23. Feng Z, Guo W, Zhang C, et al. CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma. PLoS One 2011;6:e26399
24. van Diest PJ, Michalides RJ, Jannink L, et al. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol 1997;150:705-11
25. Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011;333:1157-60
26. Chung CH, Zhang Q, Hammond EM, et al. Integrating epidermal growth factor receptor assay withclinicalparametersimproves risk classification for relapse and survival in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2011;81:331-38
27. Smith BD, Smith GL, Carter D, et al. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 2000;18:2046-52